NEW ORLEANS–(BUSINESS WIRE)–ManagementPlus, announced today that it will be exhibiting at the annual ASCRS•ASOA Symposium & Congress in New Orleans from May 6-10 as part of The Eye Care Leaders Group (ECL Group). As a member company of the ECL Group, ManagementPlus (booth #2201) now offers a full suite of electronic health record (EHR), practice management, ambulatory surgery center, revenue cycle solutions and optical solutions specifically designed to optimize eye care practices and bet
HEIDELBERG, Germany–(BUSINESS WIRE)–Novaliq GmbH announced the completion of enrollment in its Phase 2 clinical trial evaluating the safety, efficacy and tolerability of CyclASol® for the treatment of moderate to severe dry eye disease.
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Eleven Biotherapeutics reported financial results for the first quarter ended March 31, 2016 and provided a review of recent business highlights.
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova® lid and lash hygiene product for the domestic eye care market, announces that it will report first quarter 2016 financial results after market close on Thursday, May 12. Management will hold an investment community conference call that day to discuss financial results and provide a company update. DATE: Thursday, May 12 TIME:
IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced the completion of patient enrollment in the Company’s initial Phase 3 registration trial (“Mercury 1”) of RoclatanTM (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%, a novel once-daily eye drop being tested for its ability to lower intraocular pressure (IOP)
A new study has shown that Ebola survivors may be at risk of severe vision loss or blindness weeks after being declared virus-free. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology t…